The synthesis of novel 1,3-oxazolidine pyrimidine nucleoside analogues are described. These analogues are all derived from the key stereochemically defined intermediate N-tert-butoxy-carbonyl-2hydroxymethyl-l,3-oxazolidine-4-ol which was accessible in 57% yield starting from L-serine methylester hydrochloride. The heterocyclic bases eg; uracil, thymine etc are efficiently introduced onto the 1,3-oxazolidine by the Vorbruggen procedures. The antimicrobial activity of novel 1,3-oxazolidine nucleoside analogues are highlighted. The compounds 7d and 7e showed significant activity against bacteria and fungus.
No takes yet. Share an insight, caveat, or question.
Sriharsha et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: